Survey of Inhibitors in Plasma-Product Exposed Toddlers

NCT01064284 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

303

Enrollment

OTHER

Sponsor class

Conditions

Hemophilia A

Interventions

DRUG: PLASMA DERIVED Factor VIII
DRUG: Recombinant FVIII

Sponsor

Fondazione Angelo Bianchi Bonomi

Collaborators

[object Object]